US Risk Stratification System for Follicular Thyroid Neoplasms.

Jianming Li1, Chao Li1, XiaoHui Zhou1

  • 1From the Department of Interventional Ultrasound, Fifth Medical Center of Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China (J.L., J.Y., P.L.); Department of Ultrasound, The First Affiliated Hospital of Henan University of CM, Henan, China (C.L.); Department of Ultrasound Diagnostics, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Hunan, China (X.Z.); Department of Ultrasound, Peking University Third Hospital, Beijing, China (J.H.); Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, Beijing, China (P.Y.); Department of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Beijing, China (Y.C.); Department of Ultrasound, Tianjin Medical University General Hospital, Tianjin, China (H.Z.); Department of Otolaryngology-Head & Neck Surgery, The Second Affiliated Hospital of Guilin Medical University, Guangxi, China (R.H.); Department of Ultrasound, Traditional Chinese Medical Hospital of Xinjiang, Xinjiang, China (Y.M.); Department of Pathology, First Medical Center of Chinese PLA General Hospital, Beijing, China (X.G.); and Department of Pathology, Affiliated Hospital of Hebei Engineering University, Hebei, China (Y.Z.).

Radiology
|November 21, 2023
PubMed
Summary

A new ultrasound risk stratification system (F-TI-RADS) effectively differentiates follicular thyroid adenoma from follicular thyroid carcinoma. This novel system shows improved performance over existing methods for preoperative assessment of follicular thyroid neoplasms.